[Rampant linear dermatitis ("larbish"). Resistance to thiabendazole and efficacy of fluoromebendazole].
D000969:Antinematodal Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007223:Infant; D007815:Larva Migrans / Q000188:drug therapy*; D008297:Male; D008463:Mebendazole / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013827:Thiabendazole / Q000627:therapeutic use
D000969:Antinematodal Agents; D001562:Benzimidazoles; D008463:Mebendazole; D013827:Thiabendazole; C018945:flubendazole
Dermatite linéaire rampante ("Larbish"). Résistance au thiabendazole et efficacité du fluoromebendazole.